Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

ART 2612

Next Previous
Drug Profile

ART 2612

Alternative Names: ART-26.12; ART2612

Latest Information Update: 08 May 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Stony Brook University; The Research Foundation of State University of New York
  • Developer Artelo Biosciences; Stony Brook University
  • Class Antineoplastics; Anxiolytics; Non-opioid analgesics; Skin disorder therapies; Small molecules
  • Mechanism of Action FABP5 protein inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase I Peripheral neuropathies
  • Preclinical Cancer; Diabetic neuropathies; Pain; Post-traumatic stress disorders; Skin disorders

Most Recent Events

  • 28 Apr 2025 Artelo Biosciences completes enrolment in its phase I trial in Peripheral neuropathies (In volunteers) in USA (PO)
  • 13 Jan 2025 Phase-I clinical trials in Peripheral neuropathies (In volunteers) in USA (PO) (Artelo Biosciences pipeline, January 2025)
  • 13 Nov 2024 Preclinical trials in Pain in USA (PO) prior to November 2024

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top